{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:01:07Z","timestamp":1765609267455},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,3,30]],"date-time":"2005-03-30T00:00:00Z","timestamp":1112140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,30]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Carriage of CARD15 gene polymorphisms and the serological marker anti-Saccharomyces cerevisiae antibodies (ASCA) are two markers for Crohn's disease (CD). Similar phenotypes have been associated with both markers. In the present study we analysed whether both markers were associated with each other and, if so, whether this association could be explained by a direct link or by an indirect association with those phenotypes. Therefore, we included 156 consecutive Caucasian CD patients and assessed the prevalence of the three common single nucleotide polymorphisms in the CARD15 gene. Serum samples were analysed for IgA and IgG ASCA by ELISA. CD patients with CARD15 polymorphisms were more frequently ASCA positive (OR 2\u00b77 (1.4\u20135.2); P = 0\u00b7002) and had higher titres for ASCA IgA (P = 0\u00b7005) and ASCA IgG (P\u2003&amp;lt; 0\u00b7001) compared to patients carrying the wild type polymorphisms. Multivariate analysis demonstrated that this association was independent from ileal disease, penetrating disease and stricturing disease, the need for resective bowel surgery, familial cases, smoking habits and early age at onset. Homozygotes or compound heterozygotes for CARD15 polymorphisms had significantly more frequent ASCA positivity compared to single heterozygotes (OR 9\u00b71 (1.1\u201374.2), Pc (corrected P-value) = 0\u00b7030). These data indicate that there is a significant association between the carriage of CARD15 polymorphisms and ASCA, independent of the described phenotypes. Moreover, ASCA positivity is more frequent in CD patients carrying 2 CARD15 polymorphisms compared to single heterozygotes.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02759.x","type":"journal-article","created":{"date-parts":[[2005,3,30]],"date-time":"2005-03-30T10:11:11Z","timestamp":1112177471000},"page":"354-359","source":"Crossref","is-referenced-by-count":26,"title":["<i>CARD15<\/i> polymorphisms are associated with anti-<i>Saccharomyces cerevisiae<\/i> antibodies in caucasian Crohn's disease patients"],"prefix":"10.1093","volume":"140","author":[{"given":"B Vander","family":"Cruyssen","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Peeters","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I E A","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Laukens","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedical Research, Ghent University, and Flanders Interuniversity Institute for Biotechnology, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Coucke","sequence":"additional","affiliation":[{"name":"Department of Centre for Medical Genetics, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Marichal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Cuvelier","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Remaut","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedical Research, Ghent University, and Flanders Interuniversity Institute for Biotechnology, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Veys","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Mielants","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"De Vos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"De Keyser","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,3,30]]},"reference":[{"key":"2022010818040350100_b1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1046\/j.1365-2036.2002.01310.x","article-title":"Review article. the role of the gut flora in health and disease, and its modification as therapy","volume":"16","author":"Hart","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2022010818040350100_b2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","article-title":"Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study","volume":"359","author":"Hampe","year":"2002","journal-title":"Lancet"},{"key":"2022010818040350100_b3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(02)07284-7","article-title":"Crohn's disease","volume":"359","author":"Shanahan","year":"2002","journal-title":"Lancet"},{"key":"2022010818040350100_b4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM200202213460812","article-title":"Genes, microbes, and T cells-new therapeutic targets in Crohn's disease","volume":"346","author":"Elson","year":"2002","journal-title":"N Engl J Med"},{"key":"2022010818040350100_b5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"2022010818040350100_b6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frame shift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"2022010818040350100_b7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/gast.2002.35393","article-title":"Mutations in NOD2 are associated with stricturing disease in patients with Crohn's disease","volume":"123","author":"Abreu","year":"2002","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/gast.2002.32413","article-title":"The molecular classification of th clinical manifestations of Crohn's disease","volume":"122","author":"Ahmad","year":"2002","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2002.32415","article-title":"The contribution of NOD2gene mutations to the risk and site of disease in inflammatory bowel disease","volume":"122","author":"Cuthbert","year":"2002","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/341124","article-title":"CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure","volume":"71","author":"Vermeire","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2022010818040350100_b11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.52.4.558","article-title":"CARD15\/NOD2 gene variansts are associated with familially occuring and complicated forms of Crohn's disease","volume":"52","author":"Heli\u00f6","year":"2003","journal-title":"Gut"},{"key":"2022010818040350100_b12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","article-title":"CARD15\/NOD2 mutational analysis and genotype\/phenotype correlation in 612 patients with inflammatory bowel disease","volume":"70","author":"Lesage","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2022010818040350100_b13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/cdli.3.2.219-226.1996","article-title":"Specific antibody response to oligomannosidic epitopes in Crohn's disease","volume":"3","author":"Sendid","year":"1996","journal-title":"Clin Diagn Laboratory Imm"},{"key":"2022010818040350100_b14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.297.6656.1105","article-title":"Antibody to Saccharomyces cerevisiae (bakers\u2019 yeast) in Crohn's disease","volume":"297","author":"Main","year":"1988","journal-title":"Br Med J"},{"key":"2022010818040350100_b15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.31.5.536","article-title":"Antibody to selected srains of Saccharomyces cerevisiae (Baker's and brewer's yeast) and Candida albicans in Crohn's disease","volume":"310","author":"McKenzie","year":"1990","journal-title":"Gut"},{"key":"2022010818040350100_b16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic auto-antibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"2022010818040350100_b17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/gast.2001.22546","article-title":"Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease","volume":"120","author":"Vermeire","year":"2001","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00054725-200108000-00003","article-title":"Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease","volume":"7","author":"Sandborn","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2022010818040350100_b19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","article-title":"Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease","volume":"126","author":"Mow","year":"2004","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","article-title":"Anti-Saccharomyces cerevisiae antibodies, phenotypes of IBD and intestinal permeability: a study in IBD families","volume":"7","author":"Vermeire","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2022010818040350100_b21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic Value of anti-Saccharomyces cerevisiae and anti neutrophil cytoplasmic auto antibodies in inflammatory bowel disease","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2022010818040350100_b22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"2022010818040350100_b23","first-page":"1","article-title":"Negative association between smoking and anti-Saccharomyces cerevisiae antibodies in Crohn's disease","volume":"66","author":"Van Kemseke","year":"2003","journal-title":"Acta Gastroenterol Belg"},{"key":"2022010818040350100_b24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/003655201750065960","article-title":"Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a familial study","volume":"36","author":"Seibold","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"2022010818040350100_b25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000066760","article-title":"Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value","volume":"66","author":"Glas","year":"2002","journal-title":"Digestion"},{"key":"2022010818040350100_b26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/gut.33.7.909","article-title":"Antibody (IgG, IgA and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease","volume":"33","author":"Lindberg","year":"1992","journal-title":"Gut"},{"key":"2022010818040350100_b27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.46.1.58","article-title":"Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease","volume":"45","author":"Sutton","year":"2000","journal-title":"Gut"},{"key":"2022010818040350100_b28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity, but not NOD2\/CARD15 mutations","volume":"135","author":"Walker","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2022010818040350100_b29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.dld.2003.10.001","article-title":"Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn's disease population","volume":"36","author":"Linskens","year":"2004","journal-title":"Dig Liver Dis"},{"key":"2022010818040350100_b30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1006\/jaut.1995.0048","article-title":"HLA-associated heterogeneity of the humoral response to islet antigens in insulin-dependent diabetes","volume":"8","author":"Delamaire","year":"1995","journal-title":"J Autoimmun"},{"key":"2022010818040350100_b31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0140-6736(91)92234-S","article-title":"Serological markers and HLA genes among healthy first-degree relatives of patients with celiac disease","volume":"91","author":"M\u00e4ki","year":"1991","journal-title":"Lancet"},{"key":"2022010818040350100_b32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.10514","article-title":"Relationship among the HLA-DRB1 shared epitope, smoking and rheumatoid factor production in rheumatoid arthritis","volume":"47","author":"Mattey","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2022010818040350100_b33","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/art.11160","article-title":"Association of the \u22122849 Interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis","volume":"48","author":"Lard","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2022010818040350100_b34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.46.6.457","article-title":"HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens","volume":"46","author":"Smolen","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"2022010818040350100_b35","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.11103","article-title":"In primary Sj\u00f6gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2022010818040350100_b36","first-page":"101","article-title":"The genetics of Human lupus","volume-title":"Dubois\u2019 Lupus Eythematosus","author":"Tsao","year":"2002"},{"key":"2022010818040350100_b37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/art.20060","article-title":"Association of transforming growth factor \u03b21 and tumour necrosis factor \u03b1 polymorphisms with anti-SSB\/La antibody secretion in patients with primary Sj\u00f6gren's syndrome","volume":"50","author":"Gottenberg","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022010818040350100_b38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2003.50045","article-title":"The genetics of inflammatory bowel disease","volume":"124","author":"Bonen","year":"2003","journal-title":"Gastroenterology"},{"key":"2022010818040350100_b39","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1074\/jbc.M009728200","article-title":"Human Nod1 confers responsiveness to bacterial lipoppolysaccharides","volume":"276","author":"Inohara","year":"2001","journal-title":"J Biol Chem"},{"key":"2022010818040350100_b40","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.C200673200","article-title":"Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease","volume":"278","author":"Inohara","year":"2003","journal-title":"J Biol Chem"},{"key":"2022010818040350100_b41","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide detection","volume":"278","author":"Girardin","year":"2003","journal-title":"J Biol Chem"},{"key":"2022010818040350100_b42","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","article-title":"Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB","volume":"276","author":"Ogura","year":"2001","journal-title":"J Biol Chem"},{"key":"2022010818040350100_b43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/path.1276","article-title":"Cross-reactivity of yeast antigens in human colon and peripheral leukocytes","volume":"199","author":"Oshitani","year":"2003","journal-title":"J Pathol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02759.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/2\/354\/42081312\/j.1365-2249.2005.02759.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/2\/354\/42081312\/j.1365-2249.2005.02759.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T18:07:04Z","timestamp":1641665224000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/140\/2\/354\/6440493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,30]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,3,30]]},"published-print":{"date-parts":[[2005,3,30]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02759.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,5]]},"published":{"date-parts":[[2005,3,30]]}}}